Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has terminated the company’s standstill agreement with Wyeth regarding additional shipments by Teva of generic Protonix as a result of Wyeth's launch of an authorized generic product.
Subscribe to our email newsletter
Teva is currently involved in patent litigation with Wyeth concerning this product in the US District Court of New Jersey.
In September 2007, the district court denied a motion filed by Wyeth for a preliminary injunction related to Teva’s pantoprazole tablets. In that decision, the court found that Wyeth did not meet its burden of proving likelihood of success on the merits. Wyeth has appealed that decision.